Freestone Capital Holdings’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$14.6M Buy
57,366
+2,768
+5% +$645K 0.38% 42
2026
Q1
$13.3M Buy
54,598
+1,842
+3% +$429K 0.4% 44
2025
Q4
$10.9M Buy
52,756
+1,489
+3% +$294K 0.32% 54
2025
Q3
$9.51M Buy
51,267
+1,740
+4% +$298K 0.29% 57
2025
Q2
$7.57M Sell
49,527
-6,447
-12% -$991K 0.26% 68
2025
Q1
$9.28M Sell
55,974
-3,858
-6% -$604K 0.35% 55
2024
Q4
$8.65M Sell
59,832
-3,702
-6% -$574K 0.3% 58
2024
Q3
$10.3M Sell
63,534
-1,126
-2% -$179K 0.35% 57
2024
Q2
$9.45M Sell
64,660
-3,012
-4% -$448K 0.34% 56
2024
Q1
$10.7M Buy
67,672
+1,105
+2% +$176K 0.4% 49
2023
Q4
$10.4M Sell
66,567
-1,587
-2% -$243K 0.47% 42
2023
Q3
$10.6M Buy
68,154
+1,761
+3% +$291K 0.56% 40
2023
Q2
$11M Sell
66,393
-365
-0.5% -$58.9K 0.44% 43
2023
Q1
$10.3M Sell
66,758
-1,273
-2% -$206K 0.46% 36
2022
Q4
$12M Sell
68,031
-5,636
-8% -$973K 0.55% 26
2022
Q3
$12M Sell
73,667
-11,734
-14% -$1.99M 0.54% 22
2022
Q2
$15.2M Sell
85,401
-15,761
-16% -$2.81M 0.58% 21
2022
Q1
$17.9M Sell
101,162
-4,260
-4% -$725K 0.72% 25
2021
Q4
$18M Buy
105,422
+13,712
+15% +$2.24M 0.76% 25
2021
Q3
$14.8M Buy
91,710
+8,739
+11% +$1.49M 0.74% 27
2021
Q2
$13.7M Buy
82,971
+23,957
+41% +$3.97M 0.69% 28
2021
Q1
$9.7M Buy
59,014
+1,801
+3% +$291K 0.53% 40
2020
Q4
$9M Sell
57,213
-171
-0.3% -$25.2K 0.53% 38
2020
Q3
$8.54M Sell
57,384
-985
-2% -$146K 0.56% 37
2020
Q2
$8.21K Sell
58,369
-9,068
-13% -$1.32M 0.1% 44
2020
Q1
$8.84K Sell
67,437
-638
-0.9% -$90.5K 0.19% 34
2019
Q4
$9.93K Buy
68,075
+4,454
+7% +$604K 0.21% 34
2019
Q3
$8.23K Sell
63,621
-3,416
-5% -$450K 0.2% 36
2019
Q2
$9.34K Buy
67,037
+36,393
+119% +$5.04M 0.24% 34
2019
Q1
$4.28M Buy
30,644
+5,118
+20% +$686K 0.25% 111
2018
Q4
$3.29M Buy
25,526
+1,954
+8% +$273K 0.22% 119
2018
Q3
$3.26M Sell
23,572
-34,471
-59% -$4.58M 0.02% 142
2018
Q2
$7.04M Buy
58,043
+1,423
+3% +$178K 0.04% 77
2018
Q1
$7.26M Buy
56,620
+2,989
+6% +$404K 0.42% 63
2017
Q4
$7.49M Buy
53,631
+1,249
+2% +$174K 0.52% 51
2017
Q3
$6.81M Buy
52,382
+3,951
+8% +$524K 0.48% 56
2017
Q2
$6.41M Buy
48,431
+2,560
+6% +$327K 0.5% 49
2017
Q1
$5.71M Buy
45,871
+2,627
+6% +$314K 0.44% 46
2016
Q4
$4.98M Buy
43,244
+348
+0.8% +$40.2K 0.43% 49
2016
Q3
$5.07M Buy
42,896
+4,335
+11% +$526K 0.46% 45
2016
Q2
$4.68M Buy
38,561
+2,558
+7% +$291K 0.46% 42
2016
Q1
$3.9M Buy
36,003
+7,739
+27% +$801K 0.41% 41
2015
Q4
$2.9M Buy
28,264
+3,206
+13% +$322K 0.3% 46
2015
Q3
$2.34M Buy
25,058
+11,463
+84% +$1.11M 0.25% 57
2015
Q2
$1.32M Buy
13,595
+86
+0.6% +$8.61K 0.21% 75
2015
Q1
$1.36M Buy
13,509
+9,767
+261% +$993K 0.21% 66
2014
Q4
$391K Buy
3,742
+12
+0.3% +$1.26K 0.06% 146
2014
Q3
$398K Sell
3,730
-7,239
-66% -$751K 0.07% 117
2014
Q2
$1.15M Sell
10,969
-600
-5% -$60.6K 0.18% 93
2014
Q1
$1.14M Buy
11,569
+2,244
+24% +$208K 0.2% 87
2013
Q4
$854K Sell
9,325
-9,360
-50% -$863K 0.15% 115
2013
Q3
$1.44M Buy
18,685
+9,852
+112% +$884K 0.26% 71
2013
Q2
$758K Buy
+8,833
New +$750K 0.16% 122

Other funds holding JNJ

Freestone Capital Holdings's JNJ Position: Q2 2026 in Review

Freestone Capital Holdings increased its Johnson & Johnson (JNJ) stake by 5.1% in Q2 2026, buying an estimated $645K and bringing the position to 57,366 shares worth $14.6M. The position accounts for 0.38% of the portfolio, ranked #42.

Freestone Capital Holdings first reported a position in JNJ in Q2 2013 and has held it in 53 quarters since. The position peaked at $18M in Q4 2021. 4,655 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Freestone Capital Holdings held 57,366 shares of Johnson & Johnson worth $14.6M as of Q2 2026.
  • Freestone Capital Holdings bought 2,768 Johnson & Johnson shares in Q2 2026, an estimated $645K.
  • Johnson & Johnson made up 0.38% of Freestone Capital Holdings's portfolio in Q2 2026, its #42 holding.
  • Freestone Capital Holdings first reported a position in Johnson & Johnson in Q2 2013 and has held it in 53 quarters since.
  • Freestone Capital Holdings's Johnson & Johnson position peaked at $18M in Q4 2021.
  • 4,655 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Freestone Capital Holdings's 13F filing for Q2 2026, filed 31 Jul 2026.